Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Aldevron, has successfully completed the manufacturing of the TUSC2 plasmid DNA pursuant to the manufacturing agreement between Genprex and Aldevron that was announced in September 2018.
read more
EAG Laboratories has announced the launch of a new laboratory in China dedicated to improving materials, products and electronics. Built in Shanghai, this facility brings the advanced imaging and surface analysis expertise and technology to China, ...
read more
The global contract manufacturing market size is expected to reach USD 281.6 billion by 2026 registering a CAGR of 7.0%, according to a new report by Grand View Research, Inc. Increasing demand for advanced products is major factor driving the market...
read more
Cognate BioServices, a contract development and manufacturing organization in the global cellular therapies industry, has secured a financial sponsor to support its short-term and long-term growth as it closed on a round of growth capital from EW ...
read more
Grand River Aseptic Manufacturing ("GRAM"), a leading parenteral contract development and manufacturing organization, was recently ranked in Inc. Magazine's Inc. 5000 list for the third consecutive year.
read more
BiomX announced completion of construction of a new state-of-the-art manufacturing facility.
read more
Tuesday, September 03, 2019
Bora has reported a successful FDA general inspection for its facility in Zhunan, Taiwan.
read more
Wednesday, September 04, 2019
CMAB Biopharma and Kintor announced a comprehensive strategic cooperation agreement for the development and manufacturing of ALK-1 monoclonal antibody (mAb).
read more
Wednesday, September 04, 2019
The FDA has issued a Complete Response Letter for the New Drug Application for Insulin Glargine filed by the company’s partner, Mylan.
read more
Wednesday, September 04, 2019
Velesco Pharma will triple its clinical manufacturing capacity with the purchase and fit-out of a new, state-of-the-art facility in Wixom, Michigan.
read more
Monday, September 09, 2019
CMAB Biopharma announced a positive opinion in an external European quality audit conducted by Parexel International.
read more
Monday, September 09, 2019
Polpharma Biologics has entered a global commercialization agreement with Sandoz AG for a natalizumab biosimilar.
read more
Tuesday, September 10, 2019
Nichi-Iko and Sagent announced their Canadian subsidiary, Omega Laboratories, has been found acceptable for manufacturing FDA-approved products.
read more
Wednesday, September 11, 2019
ABEC has introduced the Flexible Manufacturing Platform, a fully-customizable cell culture platform for flexible, high-volume biopharmaceutical production.
read more
Thursday, September 12, 2019
Zhejiang Jiuzhou has entered into a contractual commitment for the purchase of SNPT, an API manufacturing facility in Suzhou, China.
read more